Procter & Gamble Company (the) · NYSE:PG

Procter & Gamble Company (the) — Goldman Sachs Consumer Products Symposium 2013

26 slides from Procter & Gamble Company (the)'s conference presentation, May 14, 2013

  1. Slide 1: Goldman Sachs Consumer Products Symposium 2013

    - Goldman Sachs Consumer P&G Products Symposium 2013 May 14, 2013

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements Certain statements in this release or presentation, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based,

  3. Slide 3: Regulations FD and G Disclosures

    Regulations FD and G Disclosures For a full reconciliation, please visit: www.pg.com/investors

  4. Slide 4: Jon Moeller, Chief Financial Officer

    Jon Moeller Chief Financial Officer

  5. Slide 5: Fiscal Year Targets: Organic Sales, Core EPS, Productivity

    Organic Sales Non-Manufacturing Overhead Role Reduction COGS Savings Manufacturing Productivity Core EPS* | Core EPS ex. VZ Share Repurchase | Dividend 2% to 4% 5,700 $1.2B 5% $3.80 to $4.00 $3.80 to $4.00 $0 $1.2B+ ~T% $3.96 to $4.04 $3.99 to $4.07 $6B 750+ + +2 points $0.04 to $0.16 $0.07 to $0.19

  6. Slide 6: owing

    owing Global 30% 45% 48% 51% 55% United States 15% 55% 59% 67% 74%

  7. Slide 7: Maintain Strong Developing Market Momentum

    Maintain Strong Developing Market Momentum Strengthen Core Developed Markets « Build & Leverage a Strong Innovation Pipeline Drive Cost Savings & Productivity Improvements

  8. Slide 8: Developing Markets: Current Footprint & Developing Market Sales

    Developing Markets Current Footprint & Developing Market Sales [Developed [Bi Developing -) us) ad A A P&G* Unilever** L'Oreal Colgate Developing MarketSales $345 $23B $11B $10B * Expected sales atthe endof FY'13 ** Excludes food businesses

  9. Slide 9: Developing Markets: Significant Sales and Profit Growth

    Developing Markets Significant Sales and Profit Growth Over Past 10 Years

  10. Slide 10: Developing Markets: Portfolio Expansion

    Developing Markets Portfolio Expansion South Africa Laundry India Toothpaste PROHEALTH — [Eeuall

  11. Slide 11: Developing Markets: India On-Track

  12. Slide 12: Developing Markets: Brazil On-Track

  13. Slide 13: Developing Markets: China: Making Progress - More Work to Do

    Developing Markets China: Making Progress - More Work to Do ¢ Share growing in Fabric Care, Baby Care, Blades & Razors, Batteries ¢ Improving trends in Hair Care, Feminine Care ¢ Recent interventions in Oral Care, Skin Care

  14. Slide 14: Developing Markets: Russia: Making Progress - More Work to Do

    Developing Markets Russia: Making Progress - More Work to Do ¢ Share growing in Blades & Razors, Feminine Care, Oral Care, Cosmetics ¢ Recent interventions in Fabric Care, Dish Care, Hair Care

  15. Slide 15: Developed Markets: % of Sales In-Line or Growing Value Share

    Developed Markets % of Sales In-Line or Growing Value Share Q4 Qi Q2 Q3 March BY A2 FY 13 FY 13 FY 13 FY 13 Developed 43% - United States 55% - Western Europe 30% - Japan 43%

  16. Slide 16: Developed Markets: Beauty: More Work to Do

    Developed Markets Beauty: More Work to Do * Pantene ¢ Largest hair care brand in the world * Global share -0.4% versus prior year ° Olay * Largest facial skin care brand in the world * Global share -0.9% versus prior year

  17. Slide 17: Innovation: Premium

    Innovation Premium iE z = 8 8 8

  18. Slide 18: Innovation: Mid-Tier

    Innovation Mid-Tier

  19. Slide 19: Innovation: Global Expansion

    Innovation Global Expansi

  20. Slide 20: Innovation: Value & Performance Claims

    Innovation Value & Performance Claims “1% Mass total eye care product— designed to give women eae eee « ing eyes in just “One Tide POD 3X Cleaner’ imal" outperforms the next 6 competitors... combined!” “For hair that acts up to 10 years younger”

  21. Slide 21: Productivity: Non-Manufacturing Enrollment

    Productivity At or Ahead of Plan in All Areas Non-Manufacturing Enrollment ¢ Reduced by 6,450 roles as of April 30' ¢ 750 roles (+10%) above June 30 target

  22. Slide 22: Productivity: Cost of Goods Sold

    Productivity At or Ahead of Plan in All Areas Cost of Goods Sold * Expect to deliver >$1.2bn in cost savings ¢ Manufacturing productivity up 7%, 2% pts. above 5% target

  23. Slide 23: Productivity: Marketing Spending

    Productivity At or Ahead of Plan in All Areas Marketing Spending ¢ Shifting more media to digital ¢ Maximize incremental “earned media” (free impressions) ¢ Non-media marketing spending down « Producing fewer but better commercials « Producing commercials in lower cost locations

  24. Slide 24: Productivity: Cash

    Productivity At or Ahead of Plan in All Areas Cash ¢ At or above 90% free cash flow productivity ¢ Strong working capital progress ¢ Increased quarterly dividend by 7% ¢ Share repurchase of $6bn at high-end of range

  25. Slide 25: Fiscal Year Targets: Organic Sales, Core EPS, Productivity

    Organic Sales Non-Manufacturing Overhead Role Reduction COGS Savings Manufacturing Productivity Core EPS* | Core EPS ex. VZ Share Repurchase | Dividend 2% to 4% 5,700 $1.2B 5% $3.80 to $4.00 $3.80 to $4.00 $0 $1.2B+ ~T% $3.96 to $4.04 $3.99 to $4.07 $6B 750+ + +2 points $0.04 to $0.16 $0.07 to $0.19

  26. Slide 26: Reg G Reconciliation of Non-GAAP measures

    The Procter & Gamble Company: Reg G Reconciliation of Non-GAAP measures In accordance with the SEC’s Regulation G, the following provides definitions of the non-GAAP measures used in Procter & Gamble's May 14, 2013 presentation and associated slides with the reconciliation to the most closely relate

PROCTER & GAMBLE — Goldman Sachs Consumer Products Symposium 2013 on 6ix